Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Stag2 regulates Hematopoietic Differentiation and Self-Renewal

Yotaro Ochi, MD, Ayana Kon, MD PhD, Kenichi Yoshida, MD PhD, Keisuke Kataoka, Masahiro Marshall Nakagawa, Hideki Makishima, MD,PhD,FACP., Manabu Nakayama, Haruhiko Koseki, Akifumi Takaori-Kondo, MD PhD, Seishi Ogawa, MD PhD

Blood (2017) 130 (Supplement 1): 790.

https://doi.org/10.1182/blood.V130.Suppl_1.790.790

Published: 2017

Journal Articles

Functional and Biological Implications of CUX1 Mutations and Deletions in Myeloid Neoplasms

Mai Aly, MD, Zubaidah M Ramdzan', PhD, Yasunobu Nagata, MD PhD, Suresh K. Balasubramanian, MD, Naoko Hosono, MD,PhD, Hideki Makishima, MD,PhD,FACP., Valeria Visconte, PhD, Bartlomiej P. Przychodzen, MSc, Cassandra M. Hirsch, BS, Mikkael A. Sekeres, MD MS, Alain Nepveu", PhD, Jaroslaw Maciejewski", MD,PhD,FACP.

Blood (2017) 130 (Supplement 1): 120.

https://doi.org/10.1182/blood.V130.Suppl_1.120.120

Published: 2017

Journal Articles

UTX mutations in Myeloid Neoplasms

Yasunobu Nagata, MD,PhD, Tomas Radivoyevitch, PhD, Hideki Makishima, MD PhD FACP., Cassandra M. Hirsch, BSc, Bartlomiej P Przychodzen, MSc, Teodora Kuzmanovic, BSc, Eiju Negoro, MD, PhD, Michael J. Clemente, M.S., Sudipto Mukherjee, MD, PhD, M.P.H., Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 3148.

https://doi.org/10.1182/blood.V128.22.3148.3148

Published: 2016

Journal Articles

U2AF1 Mutations in S34 and Q157 Create Distinct Molecular and Clinical Contexts

Vera Adema, PhD, Cassandra M. Hirsch, BSc, Bartlomiej P Przychodzen, MSc, Aziz Nazha, MD, Teodora Kuzmanovic, Eiju Negoro, MD, PhD, Dewen You, PhD, Hideki Makishima, MD PhD FACP., Michael J. Clemente, M.S., Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Valeria Visconte, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP

Blood (2016) 128 (22): 3155.

https://doi.org/10.1182/blood.V128.22.3155.3155

Published: 2016

Journal Articles

Clinical and Biological Implications of CUX1 Mutations in Myeloid Neoplasms

Mai Aly, Naoko Hosono, MD,PhD, Przychodzen Bartlomiej, Hideki Makishima, MD PhD FACP., Nagata Yasunobu, MDPhD, Cassandra M. Hirsch, BSc, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD

Blood (2016) 128 (22): 3156.

https://doi.org/10.1182/blood.V128.22.3156.3156

Published: 2016

Journal Articles

The Role of LUC7L2 in Splicing and MDS

Courtney Elizabeth Hershberger, BS, Naoko Hosono, MD, PhD, Jarnail Singh, PhD, Rosemary C Dietrich, M.S., Xiaorong Gu, PhD, Hideki Makishima, MD PhD FACP., Yogen Saunthararajah, MD, Jaroslaw P Maciejewski, MD PhD FACP, Richard A Padgett, PhD

Blood (2016) 128 (22): 5504.

https://doi.org/10.1182/blood.V128.22.5504.5504

Published: 2016

Journal Articles

Clinical Significance of Mutations and Copy Number Lesions on Prognosis of Patients with MDS after Unrelated Bone Marrow Transplantation

Blood (2016) 128 (22): 1971.

https://doi.org/10.1182/blood.V128.22.1971.1971

Published: 2016

Journal Articles

Combined DNA and Transcriptome Sequencing Reveals Discrete Subtypes of Myelodysplasia

Yusuke Shiozawa, MD, Luca Malcovati, MD, Anna Gallì, Andrea Pellagatti, PhD, Hiromichi Suzuki, MD PhD, Tetsuichi Yoshizato, MD PhD, Yusuke Sato, MD PhD, Keisuke Kataoka, MD PhD, Kenichi Yoshida, MD PhD, Kenichi Yoshida, MD PhD, Masashi Sanada, MD PhD, Hideki Makishima, MD PhD FACP, Yuichi Shiraishi, PhD, Kenichi Chiba, BA, Satoru Miyano, PhD, Jacqueline Boultwood, PhD, Eva Hellström-Lindberg, MD PhD, Seishi Ogawa, MD PhD, Mario Cazzola, MD

Blood (2016) 128 (22): 1974.

https://doi.org/10.1182/blood.V128.22.1974.1974

Published: 2016

Journal Articles

PHF6 Somatic Mutations and Their Functional Role in the Pathophysiology of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Bartlomiej P Przychodzen, MSc, Xiaorong Gu, PhD, Dewen You, PhD, Cassandra M. Hirsch, BSc, Michael J. Clemente, M.S., Mikkael A. Sekeres, MD MS, Aziz Nazha, MD, Hideki Makishima, MD PhD FACP., Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 2736.

https://doi.org/10.1182/blood.V128.22.2736.2736

Published: 2016

Journal Articles

the Impact of Clonal Dynamics on Prognosis and Outcome in Myelodysplastic Syndromes

Hideki Makishima, MD PhD FACP., Tetsuichi Yoshizato, MD PhD, Kenichi Yoshida, MD PhD, Mikkael A. Sekeres, MD MS, Tomas Radivoyevitch, PhD, Hiromichi Suzuki, MD PhD, Bartlomiej P Przychodzen, MSc, Yasunobu Nagata, MD, PhD, Manja Meggendorfer, PhD, Masashi Sanada, MD PhD, Yusuke Okuno, MD PhD, Cassandra M. Hirsch, BSc, Teodora Kuzmanovic, Yusuke Shiozawa, MD, Yusuke Sato, MD PhD, Aiko Sato-Otsubo, Thomas LaFramboise, PhD, Naoko Hosono, MD, PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, BA, Claudia Haferlach, MD, Wolfgang Kern, MD, Hiroko Tanaka, BA, Ines Gómez-Seguí, MD PhD, Holleh Husseinzadeh, MD, Swapna Thota, MD, Kathryn M. Guinta, Brittney Dienes, Tsuyoshi Nakamaki, MD, Shuichi Miyawaki, MD PhD, Yogen Saunthararajah, MD, Shigeru Chiba, MD, PhD, Satoru Miyano, PhD, Lee-Yung Shih, MD, Torsten Haferlach, MD, Seishi Ogawa, MD PhD, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 4287.

https://doi.org/10.1182/blood.V128.22.4287.4287

Published: 2016

Journal Articles

Clonal Events of Aplastic Anemia Related to the Evolution to Myelodysplastic Syndrome

Eiju Negoro, MD, PhD, Michael Clemente, M.S., Naoko Hosono, MD,PhD, Aziz Nazha, MD, Wenyi Shen, MD, Yasunobu Nagata, MD, PhD, Cassandra M. Hirsch, BSc, Bartlomiej P Przychodzen, MSc, Reda Z. Mahfouz, MD, PhD, Teodora Kuzmanovic, BSc, Hideki Makishima, MD PhD FACP., Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD, PhD, FACP

Blood (2016) 128 (22): 4290.

https://doi.org/10.1182/blood.V128.22.4290.4290

Published: 2016

Journal Articles

Genetic Landscape and Clonal Evolution Following 5-Aza Therapy in Patients with High-Risk Myelodysplastic Syndromes

Blood (2016) 128 (22): 4304.

https://doi.org/10.1182/blood.V128.22.4304.4304

Published: 2016

Journal Articles

NGS-Based Copy Number Analysis in 1,185 Patients with Myeloid Neoplasms

Blood (2016) 128 (22): 955.

https://doi.org/10.1182/blood.V128.22.955.955

Published: 2016

Journal Articles

Landscape of Subclonal Mutations in Myelodysplastic Syndromes (MDS) Allows for a Novel Hierarchy of Clonal Advantage By Combining Germline and Somatic Mutations

Blood (2016) 128 (22): 957.

https://doi.org/10.1182/blood.V128.22.957.957

Published: 2016

NARROW

Stag2 regulates Hematopoietic Differentiation and Self-Renewal

Functional and Biological Implications of CUX1 Mutations and Deletions in Myeloid Neoplasms

UTX mutations in Myeloid Neoplasms

U2AF1 Mutations in S34 and Q157 Create Distinct Molecular and Clinical Contexts

Clinical and Biological Implications of CUX1 Mutations in Myeloid Neoplasms

The Role of LUC7L2 in Splicing and MDS

Clinical Significance of Mutations and Copy Number Lesions on Prognosis of Patients with MDS after Unrelated Bone Marrow Transplantation

Combined DNA and Transcriptome Sequencing Reveals Discrete Subtypes of Myelodysplasia

PHF6 Somatic Mutations and Their Functional Role in the Pathophysiology of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

the Impact of Clonal Dynamics on Prognosis and Outcome in Myelodysplastic Syndromes

Clonal Events of Aplastic Anemia Related to the Evolution to Myelodysplastic Syndrome

Genetic Landscape and Clonal Evolution Following 5-Aza Therapy in Patients with High-Risk Myelodysplastic Syndromes

NGS-Based Copy Number Analysis in 1,185 Patients with Myeloid Neoplasms

Landscape of Subclonal Mutations in Myelodysplastic Syndromes (MDS) Allows for a Novel Hierarchy of Clonal Advantage By Combining Germline and Somatic Mutations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only